SCHEMBL28646250

SCHEMBL28646250

COc1c(-c2ccccc2)cc([N+](=O)[O-])c(O)c1C=O

nearest known ligand 0.49

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ CRHBP P24387 1/20 0.49
▸ CRHR2 Q13324 1/20 0.49
▸ PDE4B Q07343 3/20 0.45
▸ PDE4A P27815 2/20 0.45
▸ PDE4C Q08493 2/20 0.45
▸ PDE4D Q08499 2/20 0.45
▸ ERN1 O75460 7/20 0.44
▸ ALDH1A1 P00352 1/20 0.42
▸ TDP1 Q9NUW8 1/20 0.42
▸ ALOX5 P09917 1/20 0.41
▸ SIRT1 Q96EB6 1/20 0.41
▸ ABCB1 P08183 2/20 0.40
▸ TPMT P51580 1/20 0.40
▸ ABCC1 P33527 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28639689 0.86 CRHBP (0.46) CRHBPCRHR2ERN1ALDH1A1TDP1
SCHEMBL28641417 0.80 CRHBP (0.53) CRHBPCRHR2ERN1ALDH1A1TDP1
SCHEMBL28632790 0.80 CRHBP (0.49) CRHBPCRHR2ERN1ALDH1A1TDP1
SCHEMBL28635053 0.80 CRHBP (0.49) CRHBPCRHR2ERN1ALDH1A1TDP1
SCHEMBL29878561 0.75 CRHBP (0.49) CRHBPCRHR2PDE4BPDE4APDE4C
SCHEMBL5038000 0.72 ALDH1A1 (0.49) ALDH1A1TDP1ABCB1TPMTABCC1
SCHEMBL31027932 0.72 ERN1 (0.44) ERN1ALDH1A1TDP1
SCHEMBL11623472 0.71 CRHBP (0.64) CRHBPCRHR2ERN1ALDH1A1TDP1
SCHEMBL31253987 0.71 PDE4B (0.47) CRHBPCRHR2PDE4BPDE4APDE4C
SCHEMBL7803368 0.70 TDP1 (0.62) ALDH1A1TDP1ABCB1ABCC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113493433-B Benzopyrone derivative capable of serving as GPR35 receptor agonist, preparation method and application thereof 泰州医药城国科化物生物医药科技有限公司 2023-12-01 — — CN disclosed
CN-113493433-A Benzopyrone derivative capable of being used as GPR35 receptor agonist, preparation method and application thereof 泰州医药城国科化物生物医药科技有限公司 2021-10-12 — — CN disclosed
Send feedback